Technology | 2019.10.26
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ -- Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its lead program at international conferences. During the Festival of Biologics...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]nal-conferences-300945943.html
